Enora Dolivet - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Enora Dolivet

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

BMC Cancer|February 11, 2025

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitorsGwenn Le Gall, François Cherifi, Jordane Divoux, et al.

BMC Cancer|June 7, 2024

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkersLucie Thorel, Jordane Divoux, Justine Lequesne, et al.

Journal of Experimental & Clinical Cancer Research : CR|October 7, 2025

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical responseLucie Thorel, Enora Dolivet, Pierre-Marie Morice, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

BMC Cancer|February 11, 2025

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitorsGwenn Le Gall, François Cherifi, Jordane Divoux, et al.

BMC Cancer|June 7, 2024

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkersLucie Thorel, Jordane Divoux, Justine Lequesne, et al.

Journal of Experimental & Clinical Cancer Research : CR|October 7, 2025

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical responseLucie Thorel, Enora Dolivet, Pierre-Marie Morice, et al.

Pageof 2